Literature DB >> 7977365

Parent-of-origin effects in multiple endocrine neoplasia type 2B.

K M Carlson1, J Bracamontes, C E Jackson, R Clark, A Lacroix, S A Wells, P J Goodfellow.   

Abstract

Multiple endocrine neoplasia type 2B (MEN 2B) is characterized by medullary thyroid carcinoma, pheochromocytomas, mucosal neuromas, ganglioneuromas, and skeletal and ophthalmic abnormalities. It is observed as both inherited and sporadic disease, with an estimated 50% of cases arising de novo. A single point mutation in the catalytic core region of the receptor tyrosine kinase, RET, has been observed in germ-line DNA of MEN 2B patients. We have analyzed 25 cases of de novo disease in order to determine the parental origin of the mutated RET allele. In all cases the new mutation was of paternal origin. We observe a distortion of the sex ratio in both de novo MEN 2B patients and the affected offspring of MEN 2B transmitting males. These results suggests a differential susceptibility of RET to mutation in paternally and maternally derived DNA and a possible role for imprinting of RET during development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977365      PMCID: PMC1918453     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence.

Authors:  M Takahashi; Y Buma; H Hiai
Journal:  Oncogene       Date:  1989-06       Impact factor: 9.867

2.  Generation of a panel of somatic cell hybrids containing unselected fragments of human chromosome 10 by X-ray irradiation and cell fusion: application to isolating the MEN2A region in hybrid cells.

Authors:  P J Goodfellow; S Povey; H A Nevanlinna; P N Goodfellow
Journal:  Somat Cell Mol Genet       Date:  1990-03

3.  Paternal origin of new mutations in von Recklinghausen neurofibromatosis.

Authors:  D Jadayel; P Fain; M Upadhyaya; M A Ponder; S M Huson; J Carey; A Fryer; C G Mathew; D F Barker; B A Ponder
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

4.  Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

Authors:  M Takahashi; Y Buma; T Iwamoto; Y Inaguma; H Ikeda; H Hiai
Journal:  Oncogene       Date:  1988-11       Impact factor: 9.867

5.  Parental origin of mutations of the retinoblastoma gene.

Authors:  T P Dryja; S Mukai; R Petersen; J M Rapaport; D Walton; D W Yandell
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

6.  Preferential germline mutation of the paternal allele in retinoblastoma.

Authors:  X P Zhu; J M Dunn; R A Phillips; A D Goddard; K E Paton; A Becker; B L Gallie
Journal:  Nature       Date:  1989-07-27       Impact factor: 49.962

7.  Preferential loss of maternal alleles in sporadic Wilms' tumour.

Authors:  N Pal; R B Wadey; B Buckle; E Yeomans; J Pritchard; J K Cowell
Journal:  Oncogene       Date:  1990-11       Impact factor: 9.867

8.  Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.

Authors:  R A Norum; R G Lafreniere; L W O'Neal; T F Nikolai; J P Delaney; J C Sisson; H Sobol; G M Lenoir; B A Ponder; H F Willard
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

9.  A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting.

Authors:  H Scrable; W Cavenee; F Ghavimi; M Lovell; K Morgan; C Sapienza
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Assignment of the gene encoding the beta-subunit of the human fibronectin receptor (beta-FNR) to chromosome 10p11.2.

Authors:  P J Goodfellow; H A Nevanlinna; P Gorman; D Sheer; G Lam; P N Goodfellow
Journal:  Ann Hum Genet       Date:  1989-01       Impact factor: 1.670

View more
  52 in total

1.  Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease.

Authors:  G Fitze; M Schreiber; E Kuhlisch; H K Schackert; D Roesner
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin.

Authors:  R Trappe; F Laccone; J Cobilanschi; M Meins; P Huppke; F Hanefeld; W Engel
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

Review 3.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

4.  Oral Mucosal Neuromas Leading to the Diagnosis of Multiple Endocrine Neoplasia Type 2B in a Child With Intestinal Pseudo-obstruction.

Authors:  Cary M Qualia; Marilyn R Brown; Charlotte K Ryan; Thomas M Rossi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-03

5.  KinMutBase, a database of human disease-causing protein kinase mutations.

Authors:  K A Stenberg; P T Riikonen; M Vihinen
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

6.  [Prophylactic thyroid surgery].

Authors:  A Frilling; F Weber
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

7.  A Drosophila model of multiple endocrine neoplasia type 2.

Authors:  Renee D Read; Paul J Goodfellow; Elaine R Mardis; Nancy Novak; Jon R Armstrong; Ross L Cagan
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

8.  Recombination as a mechanism for sporadic mutation in the surfactant protein-C gene.

Authors:  Amy D McBee; Daniel J Wegner; Christopher S Carlson; Jennifer A Wambach; Ping Yang; Hillary B Heins; Ola D Saugstad; Michelle A Trusgnich; Julie Watkins-Torry; Lawrence M Nogee; Howard Henderson; F Sessions Cole; Aaron Hamvas
Journal:  Pediatr Pulmonol       Date:  2008-05

Review 9.  Base excision repair, aging and health span.

Authors:  Guogang Xu; Maryanne Herzig; Vladimir Rotrekl; Christi A Walter
Journal:  Mech Ageing Dev       Date:  2008-03-13       Impact factor: 5.432

Review 10.  Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.

Authors:  S W Moore; M G Zaahl
Journal:  Pediatr Surg Int       Date:  2008-03-26       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.